Background & Aims

In the multi-phase DAHLIA project, we develop, evaluate, and sustainably implement a digital behavioural treatment for chronic pain by using an agile, data-driven, user-informed approach. Following focus groups with patients and therapists to determine user needs and preferences (Phase 1), the treatment is now being piloted in several Swedish regions (Phase 2). The aim of this study is to gain detailed insights into within-person changes in functioning and well-being in people with chronic pain receiving the DAHLIA treatment.

Methods

An iterative approach is used to optimise the treatment, and the present mixed-method data include participants from the first iteration. Participants (i.e., people with chronic pain >3 months) were recruited through clinical settings (e.g., primary/ specialised care) in Region Kalmar and Stockholm. Data were collected using digital diaries, pre-post questionnaires (e.g., Brief Pain Inventory, Psychological inflexibility pain scale), and interviews. To monitor changes in real-time, a single-case experimental design with a 5-10-day baseline (A) and 6-8-week treatment (B) phase was used and participants completed the digital diary twice/daily reporting their level of well-being (sleep, mood, stress, fatigue) and functioning (pain avoidance, catastrophizing, self-efficacy, interference). Diary data were analysed at the individual level using visual analysis and effect size calculations, and inductive coding was applied to the qualitative information.

Results

In total, n=8 people with different pain conditions (e.g., chronic migraine, fibromyalgia, complex regional pain syndrome) participated in the first iteration (fall 2023) and data collection for iteration 2 and 3 is ongoing during the spring 2024. First iteration: One person did not use the digital diary due to technical issues and one person dropped out in week 4 (reason: too busy). Preliminary results of n=6 individuals show that all variables fluctuated over time and in several individuals, within-person trends for mood, pain self-efficacy, and/or pain catastrophizing appeared, indicating person-specific treatment effects. Full results including effect size calculations, pre-post comparisons with a 30% threshold, and complementary qualitative insights are expected by summer 2024.

Conclusions

The preliminary findings are promising, provide valuable insights into within- and between-person intervention effects, and suggest improvements for the treatment as well as the evaluation approach itself. It is expected that the future phases of the research will result in an evidence-based, feasible, and beneficial treatment ready for wide-scale implementation and continued development.

References

Study protocol: Bartels SL, Johnsson SI, Boersma K, Flink I, McCracken LM, Petersson S, Christie HL, Feldman I, Simons LE, Onghena P, Vlaeyen JWS, Wicksell RK. Development, evaluation and implementation of a digital behavioural health treatment for chronic pain: study protocol of the multiphase DAHLIA project. BMJ Open. 2022 Apr 15;12(4):e059152. doi: 10.1136/bmjopen-2021-059152. PMID: 35428645; PMCID: PMC9014062.

Presenting Author

Sara Laureen Bartels

Poster Authors

Sara Laureen Bartels

PhD

Karolinska Institutet

Lead Author

Afra Selma Taygar

Karolinska Institute

Lead Author

Suzanne Petersson

Ph.D.

Department of Medicine and Optometry, Linnaeus University, Kalmar & Region Kalmar County, Sweden

Lead Author

Haya Al Sharaa

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Lead Author

Linnéa Engman

Ph.D.

Karolinska Institute

Lead Author

Ida Flink

Karlstad University

Lead Author

Katja Boersma

PhD

School of Behavioral, Social and Legal Sciences, Örebro University

Lead Author

Lance McCracken

Uppsala University

Lead Author

Laura Simons

PhD

Stanford University School of Medicine

Lead Author

Patrick Onghena

Research Group on Methods, Individual and Cultural Differences, Affect & Social Behavior, KU Leuven

Lead Author

Johannes Vlaeyen

KU Leuven

Lead Author

Rikard Wicksell

PhD

Karolinska Institute

Lead Author

Topics

  • Treatment/Management: Interventional Therapies – Other